HL
Hakon Leffler
Co-FounderDr. Hakon Leffler, MD, PhD is a Co-Founder of Damora Therapeutics, Inc. (formerly known as Galecto, Inc.) (aka Galecto Biotech AB). Dr. Leffler is an expert in glycobiology and immunology. He serves as professor at Division of Microbiology, Immunology and Glycobiology at Lund University, Sweden. Dr. Leffler was among the first discoverers of the galectin family of proteins during his tenure at University of California, San Francisco. Dr. Leffler holds an MD and a PhD.
Positions
- Company NameDamora Therapeutics, Inc.Stock CodeDMRAPositionCo-FounderColleagues
- GWGarrett WinslowSenior VP, General Counsel & Corporate Secretary
- PEPeter Evan HarwinIndependent Chairman of the Board
- JAJennifer A. JarrettCEO, President & Director
- UJUlf J. NilssonCo-Founder
- TSTariq SethiCo-Founder
- CWChristopher W. CainIndependent Director
- MLMichael LandsittelIndependent Director
- JFJonathan FallowfieldMember of Clinical Advisory Board – Liver cirrhosis
